N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide

C129H130F5N27O17S5 — CID 158083517

About N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide

N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide (PubChem CID 158083517) has the molecular formula C129H130F5N27O17S5 and a molecular weight of 2585.96 g/mol. Its IUPAC name is N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide.

Molecular Properties

• Compound Name: N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide
• PubChem CID: 158083517
• Molecular Formula: C129H130F5N27O17S5
• Molecular Weight: 2585.96 g/mol
• Exact Mass: 2583.87
• IUPAC Name: N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide
• SMILES: CN1CCN(S(=O)(=O)Cc2ccc(CNC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)cc2)CC1.CN1CCN(S(=O)(=O)c2ccc(CNC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)cc2)CC1.O=C(NCc1ccc(CS(=O)(=O)NCC2CCCCC2)cc1)c1cncc2c1cnn2-c1ccc(F)cc1.O=C(NCc1ccc(CS(=O)(=O)NCC2CCCO2)cc1)c1cncc2c1cnn2-c1ccc(F)cc1.O=C(NCc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cncc2c1cnn2-c1ccc(F)cc1
• InChI: InChI=1S/C28H30FN5O3S.C26H27FN6O3S.C26H26FN5O4S.C25H25FN6O3S.C24H22FN5O4S/c29-23-10-12-24(13-11-23)34-27-18-30-16-26(25(27)17-32-34)28(35)31-14-21-6-8-22(9-7-21)19-38(36,37)33-15-20-4-2-1-3-5-20;1-31-10-12-32(13-11-31)37(35,36)18-20-4-2-19(3-5-20)14-29-26(34)24-15-28-17-25-23(24)16-30-33(25)22-8-6-21(27)7-9-22;27-20-7-9-21(10-8-20)32-25-16-28-14-24(23(25)15-30-32)26(33)29-12-18-3-5-19(6-4-18)17-37(34,35)31-13-22-2-1-11-36-22;1-30-10-12-31(13-11-30)36(34,35)21-8-2-18(3-9-21)14-28-25(33)23-15-27-17-24-22(23)16-29-32(24)20-6-4-19(26)5-7-20;25-18-3-5-19(6-4-18)30-23-16-26-14-22(21(23)15-28-30)24(31)27-13-17-1-7-20(8-2-17)35(32,33)29-9-11-34-12-10-29/h6-13,16-18,20,33H,1-5,14-15,19H2,(H,31,35);2-9,15-17H,10-14,18H2,1H3,(H,29,34);3-10,14-16,22,31H,1-2,11-13,17H2,(H,29,33);2-9,15-17H,10-14H2,1H3,(H,28,33);1-8,14-16H,9-13H2,(H,27,31)
• InChIKey: FNFSTQWADXMMKK-UHFFFAOYSA-N
• XLogP: 15.08
• TPSA: 528.47 Ų
• H-Bond Donors: 7
• H-Bond Acceptors: 34
• Rotatable Bonds: 37
• Heavy Atoms: 183
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2585.96
LogP ≤ 5	15.08
H-Bond Donors ≤ 5	7
H-Bond Acceptors ≤ 10	34

Frequently Asked Questions

What is the IUPAC name of N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide?

The IUPAC name of N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide (CID 158083517) is N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide.

What is the SMILES notation for N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide?

The canonical SMILES for N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide is CN1CCN(S(=O)(=O)Cc2ccc(CNC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)cc2)CC1.CN1CCN(S(=O)(=O)c2ccc(CNC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)cc2)CC1.O=C(NCc1ccc(CS(=O)(=O)NCC2CCCCC2)cc1)c1cncc2c1cnn2-c1ccc(F)cc1.O=C(NCc1ccc(CS(=O)(=O)NCC2CCCO2)cc1)c1cncc2c1cnn2-c1ccc(F)cc1.O=C(NCc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cncc2c1cnn2-c1ccc(F)cc1.

What is the InChIKey of N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide?

The InChIKey is FNFSTQWADXMMKK-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H30FN5O3S.C26H27FN6O3S.C26H26FN5O4S.C25H25FN6O3S.C24H22FN5O4S/c29-23-10-12-24(13-11-23)34-27-18-30-16-26(25(27)17-32-34)28(35)31-14-21-6-8-22(9-7-21)19-38(36,37)33-15-20-4-2-1-3-5-20;1-31-10-12-32(13-11-31)37(35,36)18-20-4-2-19(3-5-20)14-29-26(34)24-15-28-17-25-23(24)16-30-33(25)22-8-6-21(27)7-9-22;27-20-7-9-21(10-8-20)32-25-16-28-14-24(23(25)15-30-32)26(33)29-12-18-3-5-19(6-4-18)17-37(34,35)31-13-22-2-1-11-36-22;1-30-10-12-31(13-11-30)36(34,35)21-8-2-18(3-9-21)14-28-25(33)23-15-27-17-24-22(23)16-29-32(24)20-6-4-19(26)5-7-20;25-18-3-5-19(6-4-18)30-23-16-26-14-22(21(23)15-28-30)24(31)27-13-17-1-7-20(8-2-17)35(32,33)29-9-11-34-12-10-29/h6-13,16-18,20,33H,1-5,14-15,19H2,(H,31,35);2-9,15-17H,10-14,18H2,1H3,(H,29,34);3-10,14-16,22,31H,1-2,11-13,17H2,(H,29,33);2-9,15-17H,10-14H2,1H3,(H,28,33);1-8,14-16H,9-13H2,(H,27,31).

What are the key properties of N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide?

N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide has a molecular weight of 2585.96 g/mol, XLogP of 15.08, 37 rotatable bonds, 7 hydrogen bond donors, and 34 hydrogen bond acceptors.

Where does this data come from?

All data for N-[[4-(cyclohexylmethylsulfamoylmethyl)phenyl]methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-[(4-methylpiperazin-1-yl)sulfonylmethyl]phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(4-morpholin-4-ylsulfonylphenyl)methyl]pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[[4-(oxolan-2-ylmethylsulfamoylmethyl)phenyl]methyl]pyrazolo[5,4-c]pyridine-4-carboxamide is sourced from PubChem (CID 158083517), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).